61 related articles for article (PubMed ID: 19567148)
1. Direct, real-time PCR (MethyLight) assay for methylation of O6-methylguanine-DNA methyltransferase promoter in glioma.
Chen G; Wu X; Yao Y; Zhou LF; Mao Y
Chin Med J (Engl); 2009 Jun; 122(11):1342-5. PubMed ID: 19567148
[No Abstract] [Full Text] [Related]
2. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis.
Hattermann K; Mehdorn HM; Mentlein R; Schultka S; Held-Feindt J
Anal Biochem; 2008 Jun; 377(1):62-71. PubMed ID: 18384736
[TBL] [Abstract][Full Text] [Related]
3. The correlation between promoter methylation status and the expression level of O6-methylguanine-DNA methyltransferase in recurrent glioma.
Suzuki T; Nakada M; Yoshida Y; Nambu E; Furuyama N; Kita D; Hayashi Y; Hayashi Y; Hamada J
Jpn J Clin Oncol; 2011 Feb; 41(2):190-6. PubMed ID: 21148162
[TBL] [Abstract][Full Text] [Related]
4. Alterations in S-adenosylhomocysteine metabolism decrease O6-methylguanine DNA methyltransferase gene expression without affecting promoter methylation.
Hermes M; Geisler H; Osswald H; Riehle R; Kloor D
Biochem Pharmacol; 2008 Jun; 75(11):2100-11. PubMed ID: 18395186
[TBL] [Abstract][Full Text] [Related]
5. Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.
Vlassenbroeck I; Califice S; Diserens AC; Migliavacca E; Straub J; Di Stefano I; Moreau F; Hamou MF; Renard I; Delorenzi M; Flamion B; DiGuiseppi J; Bierau K; Hegi ME
J Mol Diagn; 2008 Jul; 10(4):332-7. PubMed ID: 18556773
[TBL] [Abstract][Full Text] [Related]
6. "MGMT for pt mgmt": is methylguanine-DNA methyltransferase testing ready for patient management?
Iafrate AJ; Louis DN
J Mol Diagn; 2008 Jul; 10(4):308-10. PubMed ID: 18556768
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations.
Kim JI; Suh JT; Choi KU; Kang HJ; Shin DH; Lee IS; Moon TY; Kim WT
Hum Pathol; 2009 Jul; 40(7):934-41. PubMed ID: 19356788
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics--teaching old drugs new tricks.
Weinstein JN
N Engl J Med; 2000 Nov; 343(19):1408-9. PubMed ID: 11070107
[No Abstract] [Full Text] [Related]
9. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
10. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C
J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation, field effects, and colorectal cancer.
Giovannucci E; Ogino S
J Natl Cancer Inst; 2005 Sep; 97(18):1317-9. PubMed ID: 16174847
[No Abstract] [Full Text] [Related]
12. O6-methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Rectal Adenocarcinoma After Chemoradiotherapy Treatment: Clinical Implications.
Oliver JA; Gómez-Millán J; Medina JA; Cabeza L; Perazzoli G; Jimenez-Luna C; Doello K; Ortiz R
Balkan Med J; 2019 Aug; 36(5):283-286. PubMed ID: 31199091
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of O6-methylguanine-DNA methyltransferase gene messenger RNA in gliomas by means of real-time RT-PCR and clinical response to nitrosoureas.
Tanaka S; Oka H; Fujii K; Watanabe K; Nagao K; Kakimoto A
Cell Mol Neurobiol; 2005 Sep; 25(6):1067-71. PubMed ID: 16392037
[TBL] [Abstract][Full Text] [Related]
14. Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.
Addeo R; De Santi MS; Del Prete S; Caraglia M
Cancer Chemother Pharmacol; 2009 Oct; 64(5):863-6. PubMed ID: 19639315
[No Abstract] [Full Text] [Related]
15. Impact of catechol-O-methyltransferase (COMT) gene polymorphism on promoter methylation status in gastric mucosa.
Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nagasaka M; Iwata M; Takahama K; Watanabe M; Hirata I
Anticancer Res; 2009 Jul; 29(7):2857-61. PubMed ID: 19596974
[TBL] [Abstract][Full Text] [Related]
16. O6-Methylguanine-DNA methyltransferase hypermethylation modulated by 17beta-estradiol in lung cancer cells.
Lai JC; Wu JY; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Anticancer Res; 2009 Jul; 29(7):2535-40. PubMed ID: 19596925
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics and biliary cancer: promise and pitfalls.
Whang EE
Ann Surg Oncol; 2005 May; 12(5):342-3. PubMed ID: 15843871
[No Abstract] [Full Text] [Related]
18. Direct and quantitative analysis of chromatin accessibility by MIRECAL--a Micrococcus nuclease/real-time PCR chromatin accessibility assay with locus specificity.
Graffmann N; Santourlidis S; Christ J; Wernet P; Uhrberg M
Anal Biochem; 2006 Jul; 354(2):308-10. PubMed ID: 16750813
[No Abstract] [Full Text] [Related]
19. Unique Role for a DNA Methyltransferase Isoform in Lung Cancer.
Duymich CE; Liang G
EBioMedicine; 2015 Oct; 2(10):1272-3. PubMed ID: 26629503
[No Abstract] [Full Text] [Related]
20. Relationship between methylation status of ERCC1 promoter and radiosensitivity in glioma cell lines.
Liu ZG; Chen HY; Cheng JJ; Chen ZP; Li XN; Xia YF
Cell Biol Int; 2009 Oct; 33(10):1111-7. PubMed ID: 19664717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
